Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
46,987,946
-
Share change
-
+761,009
-
Total reported value
-
$252,382,706
-
Put/Call ratio
-
30%
-
Price per share
-
$5.37
-
Number of holders
-
91
-
Value change
-
+$5,922,271
-
Number of buys
-
48
-
Number of sells
-
41
Institutional Holders of RAPTOR PHARMACEUTICAL CORP - COM (RPTP) as of Q2 2016
As of 30 Jun 2016,
RAPTOR PHARMACEUTICAL CORP - COM (RPTP) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,987,946 shares.
The largest 10 holders included
Broadfin Capital, LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, Sarissa Capital Management LP, GOLDMAN SACHS GROUP INC, BlackRock Institutional Trust Company, N.A., D. E. Shaw & Co., Inc., STATE STREET CORP, and MILLENNIUM MANAGEMENT LLC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.